We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$14.1B
AUM Growth
-$2.26B
Cap. Flow
-$2.67B
Cap. Flow %
-18.96%
Top 10 Hldgs %
31.21%
Holding
649
New
82
Increased
157
Reduced
258
Closed
99

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$119M
2
EWT icon
iShares MSCI Taiwan ETF
EWT
+$100M
3
MMM icon
3M
MMM
+$92.7M
4
ESRX
Express Scripts Holding Company
ESRX
+$83.5M
5
SHPG
Shire pic
SHPG
+$73.1M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$270M
2
MSFT icon
Microsoft
MSFT
+$195M
3
UNH icon
UnitedHealth
UNH
+$192M
4
JNJ icon
Johnson & Johnson
JNJ
+$164M
5
AAPL icon
Apple
AAPL
+$135M

Sector Composition

Rank Sector Weight
1 Technology 29.64%
2 Healthcare 19.28%
3 Financials 12.06%
4 Communication Services 9.18%
5 Consumer Discretionary 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
26
Coca-Cola
KO
$354B
$163M 1.16%
3,723,579
-287,347
-7% -$12.4M
ABT icon
27
Abbott
ABT
$180B
$156M 1.11%
2,558,239
-826,002
-24% -$50.1M
HON icon
28
Honeywell
HON
$77.1B
$142M 1.01%
1,092,368
-102,341
-9% -$13.6M
MA icon
29
Mastercard
MA
$477B
$141M 1%
715,640
-429,145
-37% -$80.7M
META icon
30
Meta Platforms (Facebook)
META
$1.51T
$137M 0.98%
707,483
-45,004
-6% -$8.13M
BDX icon
31
Becton Dickinson
BDX
$43.1B
$129M 0.92%
553,204
-42,235
-7% -$9.4M
PM icon
32
Philip Morris
PM
$301B
$128M 0.91%
1,583,000
-181,756
-10% -$15.4M
BABA icon
33
Alibaba
BABA
$269B
$124M 0.88%
666,697
-259,968
-28% -$49.6M
V icon
34
Visa
V
$677B
$124M 0.88%
932,861
+924,884
+11,594% +$119M
LQD icon
35
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$122M 0.87%
1,067,155
-200,745
-16% -$23.1M
MBT
36
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$119M 0.84%
13,467,694
-651,600
-5% -$6.46M
RY icon
37
Royal Bank of Canada
RY
$291B
$113M 0.8%
1,503,100
+369,100
+33% +$28.3M
TSM icon
38
TSMC
TSM
$2.09T
$110M 0.78%
3,017,853
-1,966,174
-39% -$77.7M
PFE icon
39
Pfizer
PFE
$140B
$108M 0.77%
3,148,513
-1,364,834
-30% -$46.6M
STM icon
40
STMicroelectronics
STM
$46B
$106M 0.75%
4,780,822
-230,678
-5% -$5.36M
ESRX
41
DELISTED
Express Scripts Holding Company
ESRX
$102M 0.72%
1,320,908
+1,112,608
+534% +$83.5M
COL
42
DELISTED
Rockwell Collins
COL
$102M 0.72%
757,000
-3,200
-0.4% -$433K
AABA
43
DELISTED
Altaba Inc
AABA
$95.5M 0.68%
1,304,100
-875,740
-40% -$65.6M
SYK icon
44
Stryker
SYK
$127B
$87.8M 0.62%
519,755
-367,622
-41% -$61.8M
NXPI icon
45
NXP Semiconductors
NXPI
$68B
$81M 0.58%
741,300
+241,060
+48% +$26.6M
AET
46
DELISTED
Aetna Inc
AET
$78M 0.55%
425,000
+167,320
+65% +$29.8M
SHPG
47
DELISTED
Shire pic
SHPG
$76.5M 0.54%
+453,200
New +$73.1M
PEP icon
48
PepsiCo
PEP
$186B
$72.5M 0.51%
666,017
-96,452
-13% -$9.96M
GSK icon
49
GSK
GSK
$103B
$68.8M 0.49%
1,365,600
+157,040
+13% +$7.91M
APH icon
50
Amphenol
APH
$188B
$67.2M 0.48%
3,084,936
-239,656
-7% -$5.22M
1
2
3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2018 Portfolio in Review

As of Q2 2018, Grantham, Mayo, Van Otterloo & Co (GMO) held 649 positions worth $14.1B, down 14% from $16.3B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $2.67B in Q2 2018, closing 99 positions and reducing 258 holdings. Its most notable exit was Monsanto Co, an estimated $270M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Shire pic worth $76.5M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2018 buy was Shire pic: 453,200 shares worth $76.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Visa in Q2 2018, an estimated $119M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2018 reduction was Microsoft, cutting an estimated $195M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Monsanto Co in Q2 2018, selling an estimated $270M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 31% of its $14.1B portfolio in Q2 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 82 new positions and closed 99 in Q2 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 14% quarter-over-quarter to $14.1B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2018, filed 14 Aug 2018.